You are here
Coronavirus (COVID-19): Information on medicines and medical devices
The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.
Please read the information below before contacting the TGA to see if your question is already answered.
Filters
Topics and product types
26 February 2021
The TGA has received applications and is assessing preliminary data for three COVID-19 vaccines using the provisional pathway and rolling review procedures.
22 February 2021
Find information on complying with the rules around advertising and importing COVID-19 vaccines
22 February 2021
Important information on how to lawfully advertise COVID-19 vaccines in Australia.
16 February 2021
The TGA has granted provisional approval to AstraZeneca Pty Ltd for its COVID-19 vaccine
16 February 2021
The TGA has granted provisional approval to AstraZeneca Pty Ltd for its COVID-19 vaccine
9 February 2021
The plan outlines five key strategies to strengthen Australia's vaccine vigilance system.
9 February 2021
At the time of approving a vaccine, the TGA publishes extensive information about the product for both health professionals and the public.
9 February 2021
A comprehensive system is in place to capture reports of adverse events following COVID-19 vaccination.
9 February 2021
Learn how the TGA continues to monitor the safety of vaccines after they are registered in Australia so that we can detect and respond to any safety concerns.
8 February 2021
Australia, through the TGA, is one of only five non-European Union regulators formally invited to participate by the European Medicines Agency (EMA)
Pages
Further information
Contact TGA Info
Tel: 1800 020 653
Email: info@tga.gov.au
Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.
Department of Health
Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.
Follow us
